Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data.

@article{Miller2005DirectCO,
  title={Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data.},
  author={Jeffrey D. Miller and Talia Foster and Luke Boulanger and Meredith J Chace and Mason W. Russell and Jenő P. Marton and Joseph Menzin},
  journal={COPD},
  year={2005},
  volume={2 3},
  pages={311-8}
}
Chronic obstructive pulmonary disease (COPD) is a costly cause of morbidity and mortality in the U.S. The objective of this study was to use contemporary national data-specifically, those from the 2000 Medical Expenditure Panel Survey (MEPS)-to estimate direct costs of COPD in the U.S. from an all-payer perspective. Due to constraints of MEPS data, indirect costs were excluded from our analyses, as were costs of long-term oxygen therapy and costs from nursing homes and long-term care facilities… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Economic burden of COPD in a Swedish cohort: the ARCTIC study

International journal of chronic obstructive pulmonary disease • 2018

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society • 2017

Action plans for COPD: strategies to manage exacerbations and improve outcomes

International journal of chronic obstructive pulmonary disease • 2016

Similar Papers

Loading similar papers…